Metropolitan Life Insurance Company (MetLife)’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-91,880	Closed	-$2.21M	–	2810
2014 Q2	$2.21M	Buy	91,880 +306	+0.3%	+$3.19K	0.02%	961
2014 Q1	$552K	Buy	91,574 +14,447	+19%	+$101K	﹤0.01%	1747
2013 Q4	$461K	Buy	77,127 +1,714	+2%	+$7.93K	﹤0.01%	1865
2013 Q3	$393K	Sell	75,413 -1,675	-2%	-$7.34K	﹤0.01%	1928
2013 Q2	$278K	Buy	+77,088	New	+$315K	﹤0.01%	2108

Metropolitan Life Insurance Company (MetLife)'s IDIX Position: Q3 2014 in Review

Metropolitan Life Insurance Company (MetLife) sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 91,880 shares — an estimated $2.21M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $2.21M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Metropolitan Life Insurance Company (MetLife) reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 91,880 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.21M.
Metropolitan Life Insurance Company (MetLife) first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Metropolitan Life Insurance Company (MetLife)'s IDENIX PHARMACEUTICALS INC position peaked at $2.21M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2014, filed 10 Nov 2014.